相关临床试验
120
62 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
5
4.2%
已完成
31
25.8%
尚未招募
57
47.5%
招募中
27
22.5%
暂无批准数据
- India's quantum science and life sciences communities convened at the National Conference on Quantum Biotechnology to advance translation of quantum science into diagnostics, imaging, drug discovery, and precision medicine. - The one-day conference, hosted by Qmet Tech at IIT Bombay, aligned with India's National Quantum Mission to build an application-driven quantum ecosystem. - Qmet Tech Foundation, the thematic hub for Quantum Sensing & Metrology, is developing high-precision quantum sensors aimed at addressing biological questions conventional instrumentation cannot reach. - Leaders emphasized converting growing industry interest into deployable technology, supporting startups, and building manufacturing and testing capability as quantum tools move toward the clinic.
- Researchers from SNBNCBS and Ashoka University developed ACSCeND, an AI framework that identifies three distinct developmental states of cancer stem-like cells from tumour gene-expression data. - ACSCeND outperformed existing computational methods and was applied to more than 25,000 tumour samples from TCGA and PRECOG databases. - Tumours enriched with pluripotent-like cancer stem cells were associated with poorer survival, higher recurrence likelihood, and reduced response to immunotherapies. - The framework builds on the team's earlier OncoMark platform, which decoded cancer progression hallmarks with over 99% predictive accuracy.
- Scientist and innovation strategist Dr. Ramji Pallela called on Osmania University life sciences students to transform academic research into market-ready products, technologies, and startups. - Pallela highlighted funding opportunities through Indian agencies including BIRAC, DBT, DST, CSIR, ICMR, and ANRF, alongside internships, fellowships, and seed funding programs. - Students were encouraged to pursue intellectual property rights, technology transfer, and interdisciplinary collaboration to move scientific discoveries from laboratories to wider use. - The session emphasized early engagement in innovation challenges and entrepreneurship programs rather than waiting until the end of academic careers.
- Scientists from Agharkar Research Institute, Pune, have developed a biodegradable nanocarrier platform that simultaneously silences two critical anti-apoptotic genes, MCL-1 and Survivin, in breast cancer cells. - The innovative system uses mesoporous silica nanoparticles functionalized with MUC1-specific aptamers to achieve precise tumor targeting while minimizing systemic toxicity. - In vivo studies in SCID mice demonstrated effective tumor accumulation, robust gene knockdown, increased apoptosis, and substantial tumor growth inhibition with minimal side effects. - This research, published in Advanced Healthcare Materials, represents a significant advancement in precision nanomedicine and RNAi-based cancer therapies.
- The Technology Development Board under India's Department of Science and Technology has awarded financial assistance to East Ocean Bio for developing the country's first platform-based CAR-NK cell therapy ecosystem. - The project targets resistant solid tumors through anti-PD-L1 CAR-NK therapy and represents a novel immunotherapeutic approach for leishmaniasis, a neglected tropical disease. - The indigenous technology platform offers off-the-shelf, allogeneic CAR-NK therapies that provide immediate availability and reduced safety risks compared to conventional CAR-T therapies. - This initiative aims to strengthen India's advanced immunotherapy capabilities while reducing reliance on imported therapies and positioning the country as a competitive player in next-generation treatments.
